Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 20

1.

The inducible costimulator (ICOS) is critical for the development of human T(H)17 cells.

Paulos CM, Carpenito C, Plesa G, Suhoski MM, Varela-Rohena A, Golovina TN, Carroll RG, Riley JL, June CH.

Sci Transl Med. 2010 Oct 27;2(55):55ra78. doi: 10.1126/scitranslmed.3000448.

2.

The role of costimulation in antibody deficiencies: ICOS and common variable immunodeficiency.

Yong PF, Salzer U, Grimbacher B.

Immunol Rev. 2009 May;229(1):101-13. doi: 10.1111/j.1600-065X.2009.00764.x. Review.

PMID:
19426217
3.

Regulation of CD4 T cell activation and effector function by inducible costimulator (ICOS).

Simpson TR, Quezada SA, Allison JP.

Curr Opin Immunol. 2010 Jun;22(3):326-32. doi: 10.1016/j.coi.2010.01.001. Epub 2010 Jan 29. Review.

PMID:
20116985
4.

CD28 and CTLA-4 coreceptor expression and signal transduction.

Rudd CE, Taylor A, Schneider H.

Immunol Rev. 2009 May;229(1):12-26. doi: 10.1111/j.1600-065X.2009.00770.x. Review.

5.

Differentiation and activation of γδ T Lymphocytes: Focus on CD27 and CD28 costimulatory receptors.

Ribot JC, Silva-Santos B.

Adv Exp Med Biol. 2013;785:95-105. doi: 10.1007/978-1-4614-6217-0_11. Review.

PMID:
23456842
6.

Follicular helper T cell in immunity and autoimmunity.

Mesquita D Jr, Cruvinel WM, Resende LS, Mesquita FV, Silva NP, Câmara NO, Andrade LE.

Braz J Med Biol Res. 2016;49(5):e5209. doi: 10.1590/1414-431X20165209. Epub 2016 Apr 19. Review.

7.

Exploiting IL-17-producing CD4+ and CD8+ T cells to improve cancer immunotherapy in the clinic.

Majchrzak K, Nelson MH, Bailey SR, Bowers JS, Yu XZ, Rubinstein MP, Himes RA, Paulos CM.

Cancer Immunol Immunother. 2016 Mar;65(3):247-59. doi: 10.1007/s00262-016-1797-6. Epub 2016 Jan 29. Review.

8.

Unifying concepts in CD28, ICOS and CTLA4 co-receptor signalling.

Rudd CE, Schneider H.

Nat Rev Immunol. 2003 Jul;3(7):544-56. doi: 10.1038/nri1131. Review.

PMID:
12876557
9.

Memory T cells need CD28 costimulation to remember.

Boesteanu AC, Katsikis PD.

Semin Immunol. 2009 Apr;21(2):69-77. doi: 10.1016/j.smim.2009.02.005. Epub 2009 Mar 5. Review.

10.

The role of ICOS and other costimulatory molecules in allergy and asthma.

Coyle AJ, Gutierrez-Ramos JC.

Springer Semin Immunopathol. 2004 Feb;25(3-4):349-59. Epub 2004 Jan 14. Review.

PMID:
14999428
11.
12.

Innate IL-17-producing cells: the sentinels of the immune system.

Cua DJ, Tato CM.

Nat Rev Immunol. 2010 Jul;10(7):479-89. doi: 10.1038/nri2800. Epub 2010 Jun 18. Review. Erratum in: Nat Rev Immunol. 2010 Aug;10(8):611. Nat Rev Immunol. 2010 Jul;10(7):following 489.

PMID:
20559326
13.

ICOS costimulation in inflammatory bowel disease.

Kanai T, Totsuka T, Tezuka K, Watanabe M.

J Gastroenterol. 2002 Nov;37 Suppl 14:78-81. Review.

PMID:
12572871
14.

IL-21: a pleiotropic cytokine with potential applications in oncology.

Croce M, Rigo V, Ferrini S.

J Immunol Res. 2015;2015:696578. doi: 10.1155/2015/696578. Epub 2015 Apr 15. Review.

15.

The immunobiology of IL-27.

Hall AO, Silver JS, Hunter CA.

Adv Immunol. 2012;115:1-44. doi: 10.1016/B978-0-12-394299-9.00001-1. Review.

PMID:
22608254
16.

ICOS Co-Stimulation: Friend or Foe?

Wikenheiser DJ, Stumhofer JS.

Front Immunol. 2016 Aug 10;7:304. doi: 10.3389/fimmu.2016.00304. eCollection 2016. Review.

17.

T-bet in disease.

Lazarevic V, Glimcher LH.

Nat Immunol. 2011 Jun 20;12(7):597-606. doi: 10.1038/ni.2059. Review.

PMID:
21685955
18.

Role of IL-21 and IL-21 receptor on B cells in HIV infection.

Pallikkuth S, Parmigiani A, Pahwa S.

Crit Rev Immunol. 2012;32(2):173-95. Review.

19.

TLR7, IFNγ, and T-bet: their roles in the development of ABCs in female-biased autoimmunity.

Rubtsova K, Marrack P, Rubtsov AV.

Cell Immunol. 2015 Apr;294(2):80-3. doi: 10.1016/j.cellimm.2014.12.002. Epub 2014 Dec 13. Review.

20.

A three-signal model of T-cell lymphoma pathogenesis.

Wilcox RA.

Am J Hematol. 2016 Jan;91(1):113-22. doi: 10.1002/ajh.24203. Epub 2015 Nov 17. Review.

Supplemental Content

Support Center